![]() ![]() Growing evidence highlights that acute and chronic health effects can occur due to occupational exposure to over 200 hazardous drugs used commonly in healthcare settings. The need to help ensure a quality environment and to protect healthcare personnel from hazardous drugs has been a topic of concern for decades. Note: General Chapter is informational and not compendially applicable.įor more information on other compounding chapters click here.ĭeveloping USP General Chapter Public Health Need Febru– Publication Date of General Chapter.May 31, 2019 – Revision Bulletin published to confirm the official date of USP General Chapter.December 1, 2019 – Official date for General Chapter.J– Revision Bulletin published to clarify the term ‘antineoplastic’ for the purpose of Chapter.These standards apply to all healthcare personnel who receive, prepare, administer, transport or otherwise come in contact with hazardous drugs and all the environments in which they are handled. USP General Chapter describes requirements including responsibilities of personnel handling hazardous drugs facility and engineering controls procedures for deactivating, decontaminating and cleaning spill control and documentation. ![]() The National Institute for Occupational Safety and Health (NIOSH) considers a drug to be hazardous if it exhibits one or more of the following characteristics in humans or animals: carcinogenicity, teratogenicity or developmental toxicity, reproductive toxicity, organ toxicity at low doses, genotoxicity, or structure and toxicity profiles of new drugs that mimic existing hazardous drugs. ![]() USP General Chapter provides standards for safe handling of hazardous drugs to minimize the risk of exposure to healthcare personnel, patients and the environment.įree Download USP GC Register for live webcast GC Infographic Pharmaceutical Analytical Impurities (PAIs). ![]()
0 Comments
Leave a Reply. |